OTTAWA, ON — BioTalent Canada is proud to announce it has been recognized as one of Canada’s Best Places to Work in 2024 by HRD Canada – the world’s leading independent… Read More
New molecule demonstrates efficacy in a challenging SCI model Expanding pipeline into new indications of ischemic stroke and ALS VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage… Read More
INNOVATION PARK, NC – IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions, and clinical research services to the life sciences industry, announced that the IQVIA SmartSolve Enterprise… Read More
U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for ABBV-951 based on observations from an inspection that did not involve ABBV-951 at one of AbbVie’s third-party manufacturing… Read More
VANCOUVER, BC – The first patient has entered the Phase II/III trial of ST-02, Sustained Therapeutic’s innovative cancer medication targeting Upper Tract Urethral Carcinoma (UTUC). A rare form of cancer,… Read More
